A Study of Bortezomib, Cyclophosphamide, and Dexamethasone in Patients With Untreated Multiple Myeloma and Planned for a High Dose Chemotherapy
Clinical trial NCT00833560 · COMPLETED
Trial details
- NCT number
- NCT00833560
- Sponsor
- Janssen-Cilag G.m.b.H
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-03-01
- Primary completion
- 2009-06-01
- Enrollment
- 401
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.